The efficacy and safety of iguratimod treatment in stable systemic lupus erythematosus: a preliminary prospective cohort study.

Zhang L, Chen M, Shen B, Shen Z, Chu Y, Huang R

Open source

DOI
10.3389/fmed.2026.1810291
Published
2026
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1810291,
  title = {The efficacy and safety of iguratimod treatment in stable systemic lupus erythematosus: a preliminary prospective cohort study.},
  author = {Zhang L and Chen M and Shen B and Shen Z and Chu Y and Huang R},
  year = {2026},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2026.1810291},
  url = {https://doi.org/10.3389/fmed.2026.1810291}
}

RIS

TY  - JOUR
TI  - The efficacy and safety of iguratimod treatment in stable systemic lupus erythematosus: a preliminary prospective cohort study.
AU  - Zhang L
AU  - Chen M
AU  - Shen B
AU  - Shen Z
AU  - Chu Y
AU  - Huang R
PY  - 2026
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1810291
UR  - https://doi.org/10.3389/fmed.2026.1810291
ER  - 

APA

L, Z., M, C., B, S., Z, S., Y, C., & R, H. (2026). The efficacy and safety of iguratimod treatment in stable systemic lupus erythematosus: a preliminary prospective cohort study.. Frontiers in medicine. https://doi.org/10.3389/fmed.2026.1810291

Source records